USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark CANTAB was filed as Word mark on 05/22/1992 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".
| Trademark form | Word mark |
| File reference | 74277845 |
| Application date | May 22, 1992 |
| Publication date | May 4, 1993 |
Trademark owner
Milton Road
Cambridge CB4 4GN
GB
Cambridge CB4 4GN
GB
Trademark representatives
goods and services
5
finished pharmaceutical products for the prevention and treatment of human and animal diseases which modulate, activate or suppress the human or animal immune system, specifically restricted to products for the prevention or treatment of autoimmune diseases (rheumatoid arthritis, myasthenia gravis, systemic lupus erythematous, multiple sclerosis), inflammatory diseases (psoriasis, Crohn's disease, ulcerative colitis, asthma, allergic reactions), benign and malignant tumors (genital condylomata and cervical cancer), viral diseases (herpes virus diseases such as oral herpes (HSV 1), genital herpes (HSV 1/2), chicken pox/shingles (varicella zoster virus), cytomegalovirus; respiratory syncytial viruses; measles viruses; human immunodeficiency viruses), microbial and parasitic infections, septic or trauma induced shock and organ transplant rejection
ID: 1374277845